Rosuvastatin Calcium Tablet
Product Images NDC 50090-7968
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 50090-7968). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure_1_time_jupiter (Rosuvastatin Tablets Figure 1)
The text provides the hazard ratio (HR) of 0.56 with a confidence interval of 95% between 0.46 and 0.69, indicating a statistically significant result based on a p-value less than 0.001. The table shows cumulative incidence percentages for two groups (RSV and Placebo) over different time periods. The number at risk and years of observation are also provided for each group.*
Figure_2-major_jupiter (Rosuvastatin Tablets Figure 2)
This is a comparison of the efficacy of Rosuva 20 mg versus Placebo 20 mg in reducing cardiovascular events in a study involving 8901 participants. The analysis includes outcomes such as the primary end point (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, and arterial revascularization. The Hazard Ratios and corresponding confidence intervals are provided for each event, showing significant reductions favoring Rosuva 20 mg. These results suggest that Rosuva 20 mg may have a beneficial effect in lowering the risk of cardiovascular events compared to a Placebo.*
Figure_3_percent_dyslipidemia (Rosuvastatin Tablets Figure 3)
Structural_formula (Rosuvastatin Tablets Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.